TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor Clarithromycin
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of multiple oral doses of clarithromycin
on the pharmacokinetics of TAK-438 and its metabolites in healthy male adult participants
following a single oral dose of TAK-438.